Integration of Palliative Care in Pediatric Onco-hematology
PALONCOPED
PALONCOPED - Integration of Palliative Care in Pediatric Onco-hematology
1 other identifier
observational
45
0 countries
N/A
Brief Summary
PALONCOPED is a multicentre, interregional, observational and qualitative study aiming to better understand the early integration of palliative care in children with cancer. This study compares the practices, representations and temporalities of integration according to the type of cancer, in particular between hematological malignancies and solid tumors. The study seeks to identify the obstacles and levers encountered by professionals in pediatric onco-haematology and pediatric palliative care resource teams. It will be conducted in the hospitals of Nantes, Angers and Tours, based on about 45 semi-structured individual interviews with healthcare professionals. The data will be analyzed according to a reflexive thematic analysis, supplemented if relevant by a lexical analysis. The project aims to identify ways to improve for organizational and relational improvement, to strengthen collaboration between teams, and to promote earlier, coordinated care pathways adapted to children and their families.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2026
CompletedFirst Posted
Study publicly available on registry
September 24, 2026
CompletedStudy Start
First participant enrolled
November 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
Study Completion
Last participant's last visit for all outcomes
May 1, 2027
September 24, 2026
September 1, 2026
6 months
September 18, 2026
September 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identify the barriers and levers for the early integration of palliative care into pediatric oncology-hematology care, depending on the type of pathology (malignant blood diseases versus so-lide tumors)
Inclusion (Day 0)
Study Arms (1)
PALONCOPED Study population
We will focus on healthcare professionals working in pediatric onco-haematology services and within the Pediatric Palliative Support Care Teams.
Interventions
Only one semi-structured interview will be conducted per participant. It is estimated that the average duration of interviews is 45 minutes (given for information purposes to allow participants to anticipate the time needed for this interview). Individual interviews will be conducted by 1 researcher in Psychology. The researcher is trained in qualitative medicine and semi-structured interviews. He has extensive experience in this field.
Eligibility Criteria
We will focus on health professionals working in pediatric onco-hematology services and within the Pediatric Palliative Support Care Team. Participation in the study will be offered to professionals from targeted services by the research team directly in the services via both information by email, a poster in the break rooms and a project presentation meeting.
You may qualify if:
- Healthcare professional (doctor with a thesis that has validated his DES, qualified nurse or puériculturist, qualified childcare assistant or nursing assistant, qualified psychologist, qualified physiotherapist/occupational therapist) practicing in pediatric onco-hematology or within the Pediatric Palliative Support Care Team of three university hospital centers: Nantes, Angers, and Tours., with regular exercise for at least 3 months.
- Having been involved in supporting a child in a palliative situation in the last 9 months.
- Agreement of professionals to participate in the study, to record and transcribe interviews.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nantes University Hospitallead
- Association CASSANDRAcollaborator
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Estelle THEBAUD
Nantes UH
- PRINCIPAL INVESTIGATOR
Adrien EVIN
Nantes UH
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2026
First Posted
September 24, 2026
Study Start (Estimated)
November 1, 2026
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
May 1, 2027
Last Updated
September 24, 2026
Record last verified: 2026-09